Welcome to our dedicated page for Veralto SEC filings (Ticker: VLTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Veralto's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Veralto's regulatory disclosures and financial reporting.
Veralto Corp (VLTO) reported that officer Surekha Trivedi, SVP, Strategy & Sustainability, sold 986 shares of common stock on August 17, 2026 at $97.05 per share in an open‑market or private transaction. Following the sale, Trivedi directly holds 8,565 shares. The transaction was effected under a previously disclosed Rule 10b5‑1 trading plan adopted on May 18, 2026.
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 13,722,619 shares of Veralto Corp common stock on a Schedule 13G, representing 5.6% of the class as of June 30, 2026. It holds sole voting power over 13,257,448 shares and sole dispositive power over all 13,722,619 shares, with no shared voting or dispositive power reported. The filer states that this report should not be construed as an admission of beneficial ownership.
Veralto Corp President and CEO Jennifer Honeycutt exercised employee stock options covering 7,097 shares of common stock at $28.767,097$101.52Rule 10b5-1 trading plan adopted on February 25, 2026. After the exercise, 7,098
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of Veralto Corp common stock. BlackRock reports beneficial ownership of 20,884,996 shares, representing 8.5% of Veralto’s outstanding common stock.
BlackRock has sole voting power over 19,179,723 shares and sole dispositive power over 20,884,996 shares, with no shared voting or dispositive power. The filing explains that various underlying clients have rights to dividends and sale proceeds, but no single person has an interest exceeding five percent of Veralto’s outstanding common shares.
Jennifer Honeycutt filed to sell 7,097 shares of VLTO common stock through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $720,487.44, on or after July 29, 2026 on the NYSE. The shares relate to a stock option exercise from the issuer for cash. The filing also lists a prior sale of 7,097 shares of common stock on July 17, 2026 for $674,215.00.
Veralto Corp director Thomas Williams reported a quarterly company contribution under the Non-Employee Directors' Deferred Compensation Plan, credited as 183 unfunded, notional shares of common stock on July 24, 2026 at $92.02 per notional share, increasing his deferred account balance to 183 equivalent shares.
Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan’s terms and his elections.
Veralto Corp reported that director Cindy L. Wallis-Lage received a quarterly Company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, credited as 38 notional shares of common stock at $92.02 per share on July 24, 2026. These unfunded, notional shares convert one-for-one into common stock, with vesting and distribution governed by the plan and her prior elections.
Veralto Corp reported that director Heath A. Mitts received a quarterly company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, deemed invested in 154.0000 unfunded, notional shares of Veralto common stock as of July 24, 2026 at a reference price of 92.0200 per notional share. Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan terms and the director’s elections as described in Veralto’s annual meeting proxy statement.
Veralto Corporation reported stronger results for the three-month period ended July 3, 2026, with sales of $1,474 million, up 7.6% year over year, and net earnings of $241 million, up from $222 million. Gross margin improved to 61.2% driven by pricing, productivity and tariff recoveries. Diluted EPS was $0.98 for the quarter and $2.00 for the first six months on $2,896 million of year‑to‑date sales and $495 million of net earnings.
Water Quality segment sales rose to $908 million in the quarter and $1,782 million year to date, helped by the January acquisition of In‑Situ for $426 million. Product Quality & Innovation delivered $566 million in quarterly sales. Recurring revenue reached $915 million in the quarter and $1,802 million year to date, about 62% of total.
Operating cash flow for the first six months was $522 million. Veralto funded two acquisitions, including GlobalVision for $195 million, issued $725 million of 4.85% senior notes due 2032 and ended with $2,119 million of cash and $3,379 million of debt. The company repurchased $434 million of stock and began a multi‑year 2026 Cost Optimization Program, recording $29 million of restructuring charges toward an expected $85–$105 million total through 2028.